- Home
- BTMD
BTMD
Biote Corp.
as 04-25-2025 4:00pm EST
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | IRVING |
| Market Cap: | 104.2M | IPO Year: | N/A |
| Target Price: | $8.00 | AVG Volume (30 days): | 151.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.09 | EPS Growth: | -30.22 |
| 52 Week Low/High: | $3.04 - $8.44 | Next Earning Date: | 05-07-2025 |
| Revenue: | $197,191,000 | Revenue Growth: | 6.38% |
| Revenue Growth (this year): | 6.2% | Revenue Growth (next year): | 9.24% |
Stock Insider Trading Activity of Biote Corp. (BTMD)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Guines LLC | BTMD | 10% Owner | Apr 8 '25 | Buy | $3.21 | 48,439 | $155,387.68 | 4,156,426 | |
| Guines LLC | BTMD | 10% Owner | Apr 3 '25 | Buy | $3.21 | 74,440 | $237,405.51 | 4,156,426 | |
| Guines LLC | BTMD | 10% Owner | Mar 31 '25 | Buy | $3.32 | 106,000 | $351,920.00 | 4,156,426 | |
| HEYER ANDREW R | BTMD | Director | Mar 17 '25 | Buy | $3.95 | 75,000 | $296,042.50 | 370,201 | |
| Beer Marc D | BTMD | Director | Mar 17 '25 | Buy | $3.87 | 107,794 | $417,162.78 | 107,794 | |
| Cone Stephen Mark | BTMD | Director | Mar 17 '25 | Buy | $3.88 | 38,104 | $147,843.52 | 160,829 | |
| Christensen Bret | BTMD | Chief Executive Officer | Mar 17 '25 | Buy | $3.87 | 37,595 | $145,492.65 | 37,595 | |
| Guines LLC | BTMD | 10% Owner | Mar 13 '25 | Buy | $3.48 | 1,713,218 | $5,568,838.51 | 4,156,426 |
Latest Biote Corp. News
BTMD Breaking Stock News: Dive into BTMD Ticker-Specific Updates for Smart Investing
Business Wire
2 days ago
Biote Schedules First Quarter 2025 Financial Results Release and Conference Call
Insider Monkey
23 days ago
biote Corp. (BTMD): Insider Were Buying In Q1 2025
Argus Research
a month ago
Daily – Vickers Top Buyers & Sellers for 03/20/2025
Simply Wall St.
a month ago
Marc Beer Buys Handful Of Shares In biote
Argus Research
a month ago
Daily – Vickers Top Buyers & Sellers for 03/19/2025
Business Wire
a month ago
Biote Announces Purchase of Shares by Directors and CEO
Simply Wall St.
a month ago
biote Full Year 2024 Earnings: EPS Misses Expectations
Thomson Reuters StreetEvents
a month ago
Q4 2024 Biote Corp Earnings Call
Compare BTMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BTMD Biote Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.